There is data supporting the opinion that the use of EMFs has effects in the cell proliferation
and in malignant tumours in animals (Tofani et al., 2001; Yamaguchi et al., 2006). It has also
been reported that EMFs could act synergistically with chemotherapeutic agents (Gray et al,
2000; Ruiz Gómez et al., 2002), and reverse the resistance of cancer cells in chemotherapy
(Hirata et al., 2001; Janigro et al., 2006). Certain clinical studies have shown that the
application of EMFs in cancer patients, does not present side effects or toxicity (Barbault et
al., 2009; Roncheto et al., 2004). Existed data, also indicate that they prolong the survival
time of patients and inhibit the disease progression (Barbault et al., 2009; Kirson et al., 2007).
Consequently, EMFs can be used as a low-cost, safe and adjuvant treatment of the existing
anticancer therapy.
http://cdn.intechopen.com/pdfs/37400.pdf
No comments:
Post a Comment